T/GDACM 0119-2023 Active

Main technical content: Breast cancer has become the most common cancer among women worldwide, and it is also the leading cause of cancer death among women. The age of onset of breast cancer is tending to be younger. With the continuous progress of screening methods and treatment options, the survival rate of breast cancer has significantly increased, and improving the quality of life of tumor patients has gradually become one of the important goals of future clinical work. The breast is the second sex characteristic of women. Surgery and subsequent radiotherapy and chemotherapy have an immeasurable impact on women's physical and mental health and social and family relationships, and the impact on patients' mental health is also becoming increasingly prominent. Domestic and international surveys show that among all cancer patients, the incidence of emotional disorders in breast cancer patients is the highest. The global prevalence of depression in breast cancer patients is 32.2%, and the prevalence of anxiety is as high as 41.9%. Emotional problems not only affect patients' treatment compliance and treatment effect, but also increase the risk of related complications, thereby reducing quality of life and affecting the prognosis of the disease. Poor treatment effect can further exacerbate patients' negative emotions such as tension, anxiety, and depression, forming a vicious circle. Therefore, while treating tumors, paying attention to patients' psychological changes, early identification and reasonable intervention of patients' emotional problems are of great value in improving patients' quality of life and controlling the prognosis of the disease. Traditional Chinese medicine has many advantages in treating emotional disorders, such as good efficacy, few adverse reactions, and easy acceptance by patients. However, the factors affecting the occurrence of emotional disorders in female breast cancer patients are complex. At present, there is no consensus on the etiolo